Citation

Gebhart F. Drug Topics 2022; 166(9): 40-41.

Copyright

(Copyright © 2022)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; suicide; cannabis; prescription; Cannabis sativa; drug industry; health care personnel; drug screening; drug approval; drug formulation; Note; controlled substance; tetrahydrocannabinol; cannabidiol; drug testing challenge